These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 15184901)

  • 1. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination.
    Karnezis T; Mandemakers W; McQualter JL; Zheng B; Ho PP; Jordan KA; Murray BM; Barres B; Tessier-Lavigne M; Bernard CC
    Nat Neurosci; 2004 Jul; 7(7):736-44. PubMed ID: 15184901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
    Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
    Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q; Cai W; Li S; Zhang Y; Su B
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
    Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccination efficiently induces antibodies to Nogo-A and does not exacerbate experimental autoimmune encephalomyelitis.
    Bourquin C; van der Haar ME; Anz D; Sandholzer N; Neumaier I; Endres S; Skerra A; Schwab ME; Linington C
    Eur J Pharmacol; 2008 Jun; 588(1):99-105. PubMed ID: 18495110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.
    Chen MS; Huber AB; van der Haar ME; Frank M; Schnell L; Spillmann AA; Christ F; Schwab ME
    Nature; 2000 Jan; 403(6768):434-9. PubMed ID: 10667796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant DNA vaccine encoding multiple domains related to inhibition of neurite outgrowth: a potential strategy for axonal regeneration.
    Xu G; Nie DY; Chen JT; Wang CY; Yu FG; Sun L; Luo XG; Ahmed S; David S; Xiao ZC
    J Neurochem; 2004 Nov; 91(4):1018-23. PubMed ID: 15525355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid induction of autoantibodies against Nogo-A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases.
    Merkler D; Oertle T; Buss A; Pinschewer DD; Schnell L; Bareyre FM; Kerschensteiner M; Buddeberg BS; Schwab ME
    FASEB J; 2003 Dec; 17(15):2275-7. PubMed ID: 14563689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
    Kassis I; Petrou P; Halimi M; Karussis D
    Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lipid sulfatide is a novel myelin-associated inhibitor of CNS axon outgrowth.
    Winzeler AM; Mandemakers WJ; Sun MZ; Stafford M; Phillips CT; Barres BA
    J Neurosci; 2011 Apr; 31(17):6481-92. PubMed ID: 21525289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligodendrocyte precursor cells differentially expressing Nogo-A but not MAG are more permissive to neurite outgrowth than mature oligodendrocytes.
    Ma Z; Cao Q; Zhang L; Hu J; Howard RM; Lu P; Whittemore SR; Xu XM
    Exp Neurol; 2009 May; 217(1):184-96. PubMed ID: 19236864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
    Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
    Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to the extracellular domain of Nogo-A modulates experimental autoimmune encephalomyelitis.
    Fontoura P; Ho PP; DeVoss J; Zheng B; Lee BJ; Kidd BA; Garren H; Sobel RA; Robinson WH; Tessier-Lavigne M; Steinman L
    J Immunol; 2004 Dec; 173(11):6981-92. PubMed ID: 15557195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
    Gilgun-Sherki Y; Panet H; Melamed E; Offen D
    Brain Res; 2003 Nov; 989(2):196-204. PubMed ID: 14556941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration.
    Dimou L; Schnell L; Montani L; Duncan C; Simonen M; Schneider R; Liebscher T; Gullo M; Schwab ME
    J Neurosci; 2006 May; 26(21):5591-603. PubMed ID: 16723516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
    Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
    J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of a newly identified serine protease in CNS demyelination.
    Scarisbrick IA; Blaber SI; Lucchinetti CF; Genain CP; Blaber M; Rodriguez M
    Brain; 2002 Jun; 125(Pt 6):1283-96. PubMed ID: 12023317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells.
    Nyatia E; Lang DM
    Res Vet Sci; 2007 Dec; 83(3):287-301. PubMed ID: 17428512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats.
    Lenzlinger PM; Shimizu S; Marklund N; Thompson HJ; Schwab ME; Saatman KE; Hoover RC; Bareyre FM; Motta M; Luginbuhl A; Pape R; Clouse AK; Morganti-Kossmann C; McIntosh TK
    Neuroscience; 2005; 134(3):1047-56. PubMed ID: 15979242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.